• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示电抽搐治疗在治疗抵抗性抑郁症患者中的表观基因组特征和疗效:一项前瞻性纵向研究。

Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study.

机构信息

Department of Molecular and Translational Medicine, Biology and Genetic Division, University of Brescia, Viale Europa, 11, 25123, Brescia, Italy.

Department of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.

出版信息

Clin Epigenetics. 2024 Jul 17;16(1):93. doi: 10.1186/s13148-024-01704-z.

DOI:10.1186/s13148-024-01704-z
PMID:39020437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11256624/
Abstract

BACKGROUND

Electroconvulsive therapy (ECT) benefits patients with treatment-resistant depression (TRD), but the underlying biological processes are unclear. We conducted an epigenome-wide association study in 32 TRD patients undergoing ECT to depict ECT-associated methylation changes. Illness severity and ECT outcomes were assessed with the Montgomery-Åsberg Depression Rating Scale at baseline (T0) and 1 month after its end (T1). Methylation was profiled at T0 and T1 with the Illumina Infinium Methylation EPIC BeadChip array.

RESULTS

Longitudinal T0-T1 analyses showed 3 differentially methylated probes (DMPs) with nominal p values ≤ 10, with 2 annotated in the genes CYB5B and PVRL4. Including covariates, we found 4 DMPs for symptoms variation, annotated in FAM20C, EPB41, OTUB1 and ADARB1, and 3 DMPs for response status, with 2 annotated in IQCE and FAM20C. Regional analysis revealed 54 differentially methylated regions (DMRs) with nominal p value area ≤ 0.05, with 9 presenting adjusted p-value area ≤ 0.10, annotated in MCF2L, SLC25A24, RUNX3, MIR637, FOXK2, FAM180B, POU6F1, ALS2CL and CCRL2. Considering covariates, we found 21 DMRs for symptoms variation and 26 DMRs for response (nominal p value area ≤ 0.05), with 4 presenting adjusted p-value area ≤ 0.10 for response, annotated in SNORD34, NLRP6, GALNT2 and SFT2D3. None remained significant after false discovery rate correction. Notably, ADARB1 variants are associated with suicide attempt in patients with psychiatric disorders, and SLC25A24 relates to conduct disorder. Several DMPs and DMRs are annotated in genes associated with inflammatory/immune processes. Longitudinal analyses on females (n = 22) revealed statistically significant DMRs (adjusted p value area ≤ 0.05) and trend-significant DMRs (adjusted p value area ≤ 0.07) for symptoms variation and response status, annotated in genes related to psychiatric disorders (ZFP57, POLD4, TRIM10, GAS7, ADORA2A, TOLLIP), trauma exposure (RIPOR2) and inflammatory/immune responses (LAT, DLX4, POLD4, FAM30A, H19). Pathway analysis on females revealed enrichment for transcriptional activity, growth factors, DNA maintenance, and immune pathways including IRF7 and IRF2.

CONCLUSION

Although no significant results were found for the whole cohort, the study provides insights into ECT-associated methylation changes, highlighting DMPs and DMRs related to ECT outcomes. Analyses on females revealed significant DMRs and pathways related to psychiatric disorders and inflammatory/immune processes.

摘要

背景

电抽搐疗法(ECT)对治疗抵抗性抑郁症(TRD)患者有益,但潜在的生物学过程尚不清楚。我们对 32 名接受 ECT 的 TRD 患者进行了全基因组关联研究,以描绘 ECT 相关的甲基化变化。在基线(T0)和结束后 1 个月(T1),使用蒙哥马利-阿斯伯格抑郁评定量表评估疾病严重程度和 ECT 结果。T0 和 T1 时使用 Illumina Infinium Methylation EPIC BeadChip 阵列进行甲基化分析。

结果

纵向 T0-T1 分析显示有 3 个具有名义 p 值≤10 的差异甲基化探针(DMP),其中 2 个注释在 CYB5B 和 PVRL4 基因中。包括协变量后,我们发现 4 个用于症状变化的 DMP,注释在 FAM20C、EPB41、OTUB1 和 ADARB1 中,3 个用于反应状态的 DMP,其中 2 个注释在 IQCE 和 FAM20C 中。区域分析显示有 54 个差异甲基化区域(DMR),名义 p 值区域≤0.05,其中 9 个具有调整后的 p 值区域≤0.10,注释在 MCF2L、SLC25A24、RUNX3、MIR637、FOXK2、FAM180B、POU6F1、ALS2CL 和 CCRL2 中。考虑到协变量,我们发现 21 个用于症状变化,26 个用于反应的 DMR(名义 p 值区域≤0.05),其中 4 个用于反应的 DMR 具有调整后的 p 值区域≤0.10,注释在 SNORD34、NLRP6、GALNT2 和 SFT2D3 中。在假发现率校正后,没有一个结果仍然显著。值得注意的是,ADARB1 变体与精神障碍患者的自杀企图有关,SLC25A24 与行为障碍有关。几个 DMP 和 DMR 注释在与炎症/免疫过程相关的基因中。对女性(n=22)的纵向分析显示,对于症状变化和反应状态有统计学显著的 DMR(调整后的 p 值区域≤0.05)和趋势显著的 DMR(调整后的 p 值区域≤0.07),注释在与精神障碍(ZFP57、POLD4、TRIM10、GAS7、ADORA2A、TOLLIP)、创伤暴露(RIPOR2)和炎症/免疫反应(LAT、DLX4、POLD4、FAM30A、H19)相关的基因中。对女性的途径分析显示,转录活性、生长因子、DNA 维持以及包括 IRF7 和 IRF2 在内的免疫途径富集。

结论

尽管整个队列没有发现显著结果,但该研究提供了 ECT 相关甲基化变化的见解,突出了与 ECT 结果相关的 DMP 和 DMR。对女性的分析显示,与精神障碍和炎症/免疫过程相关的有意义的 DMR 和途径。

相似文献

1
Unraveling epigenomic signatures and effectiveness of electroconvulsive therapy in treatment-resistant depression patients: a prospective longitudinal study.揭示电抽搐治疗在治疗抵抗性抑郁症患者中的表观基因组特征和疗效:一项前瞻性纵向研究。
Clin Epigenetics. 2024 Jul 17;16(1):93. doi: 10.1186/s13148-024-01704-z.
2
DNA methylation changes in association with trauma-focused psychotherapy efficacy in treatment-resistant depression patients: a prospective longitudinal study.创伤聚焦心理疗法治疗难治性抑郁症患者疗效与 DNA 甲基化改变的相关性:一项前瞻性纵向研究。
Eur J Psychotraumatol. 2024;15(1):2314913. doi: 10.1080/20008066.2024.2314913. Epub 2024 Feb 16.
3
Epigenome-wide association study of Alzheimer's disease replicates 22 differentially methylated positions and 30 differentially methylated regions.阿尔茨海默病的全基因组表观遗传关联研究复制了 22 个差异甲基化位置和 30 个差异甲基化区域。
Clin Epigenetics. 2020 Oct 17;12(1):149. doi: 10.1186/s13148-020-00944-z.
4
Epigenome-wide analysis in newborn blood spots from monozygotic twins discordant for cerebral palsy reveals consistent regional differences in DNA methylation.对脑瘫不一致的同卵双胞胎新生儿血斑的全基因组表观遗传分析显示 DNA 甲基化存在一致的区域性差异。
Clin Epigenetics. 2018 Feb 23;10:25. doi: 10.1186/s13148-018-0457-4. eCollection 2018.
5
BDNF Genotype and Baseline Serum Levels in Relation to Electroconvulsive Therapy Effectiveness in Treatment-Resistant Depressed Patients.脑源性神经营养因子基因型与基线血清水平与电抽搐治疗难治性抑郁症患者疗效的关系。
J ECT. 2019 Sep;35(3):189-194. doi: 10.1097/YCT.0000000000000583.
6
Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.氯胺酮与电抽搐治疗抵抗性抑郁症的比较:一项随机临床试验的二次分析。
JAMA Netw Open. 2024 Jun 3;7(6):e2417786. doi: 10.1001/jamanetworkopen.2024.17786.
7
DNA methylation and smoking in Korean adults: epigenome-wide association study.韩国成年人的DNA甲基化与吸烟:全表观基因组关联研究。
Clin Epigenetics. 2016 Sep 22;8:103. doi: 10.1186/s13148-016-0266-6. eCollection 2016.
8
DNA methylation and stroke prognosis: an epigenome-wide association study.DNA 甲基化与中风预后:一项表观基因组关联研究。
Clin Epigenetics. 2024 Jun 6;16(1):75. doi: 10.1186/s13148-024-01690-2.
9
Inflammation and Improvement of Depression Following Electroconvulsive Therapy in Treatment-Resistant Depression.电抽搐治疗难治性抑郁症后炎症与抑郁改善。
J Clin Psychiatry. 2018 Mar/Apr;79(2). doi: 10.4088/JCP.17m11597.
10
Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy.ECT 反应预测的新候选基因:一项对接受电抽搐治疗的抑郁症患者 DNA 甲基组进行分析的初步研究。
Clin Epigenetics. 2020 Jul 29;12(1):114. doi: 10.1186/s13148-020-00891-9.

引用本文的文献

1
New insights into the mechanisms of electroconvulsive therapy in treatment-resistant depression.对难治性抑郁症中电休克治疗机制的新见解。
Front Psychiatry. 2025 Aug 14;16:1614076. doi: 10.3389/fpsyt.2025.1614076. eCollection 2025.

本文引用的文献

1
Molecular mechanisms underlying structural plasticity of electroconvulsive therapy in major depressive disorder.电惊厥疗法治疗重性抑郁障碍的结构可塑性的分子机制。
Brain Imaging Behav. 2024 Aug;18(4):930-941. doi: 10.1007/s11682-024-00884-9. Epub 2024 Apr 26.
2
Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.PVRL4 的表达,一种癌症治疗的分子靶标,受 FOS 的转录调控。
Oncol Rep. 2024 Jan;51(1). doi: 10.3892/or.2023.8676. Epub 2023 Dec 8.
3
MCF2L-AS1/miR-874-3p/STAT3 feedback loop contributes to lung adenocarcinoma cell growth and cisplatin resistance.MCF2L-AS1/miR-874-3p/STAT3反馈环促进肺腺癌细胞生长和顺铂耐药。
Heliyon. 2023 Oct 29;9(11):e21342. doi: 10.1016/j.heliyon.2023.e21342. eCollection 2023 Nov.
4
IRF7: role and regulation in immunity and autoimmunity.IRF7:在免疫和自身免疫中的作用和调节。
Front Immunol. 2023 Aug 10;14:1236923. doi: 10.3389/fimmu.2023.1236923. eCollection 2023.
5
Biological markers of sex-based differences in major depressive disorder and in antidepressant response.性别差异在重度抑郁症和抗抑郁反应中的生物学标志物。
Eur Neuropsychopharmacol. 2023 Nov;76:89-107. doi: 10.1016/j.euroneuro.2023.07.012. Epub 2023 Aug 16.
6
Epigenetic modification related to cognitive changes during a cognitive training intervention in depression.抑郁认知训练干预中认知变化相关的表观遗传修饰。
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Dec 20;127:110835. doi: 10.1016/j.pnpbp.2023.110835. Epub 2023 Jul 27.
7
CCRL2 Expression by Specialized Lung Capillary Endothelial Cells Controls NK-cell Homing in Lung Cancer.特异性肺毛细血管内皮细胞表达 CCRL2 控制 NK 细胞在肺癌中的归巢。
Cancer Immunol Res. 2023 Sep 1;11(9):1280-1295. doi: 10.1158/2326-6066.CIR-22-0951.
8
DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy.POMC 和 NR3C1-1F 的 DNA 甲基化及其在重度抑郁症和电惊厥治疗中的意义。
Pharmacopsychiatry. 2023 Mar;56(2):64-72. doi: 10.1055/a-2034-6536. Epub 2023 Mar 21.
9
RUNX3 in Stem Cell and Cancer Biology.RUNX3 在干细胞和癌症生物学中的作用。
Cells. 2023 Jan 25;12(3):408. doi: 10.3390/cells12030408.
10
INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer's disease.INPP5D 缺乏症可减轻阿尔茨海默病小鼠模型中的淀粉样蛋白病理。
Alzheimers Dement. 2023 Jun;19(6):2528-2537. doi: 10.1002/alz.12849. Epub 2022 Dec 16.